# FDA Inspection 1179443 - REDHILL BIOPHARMA INC. - August 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/redhill-biopharma-inc/81be1351-93a8-4705-ac08-a135b0958353
Source feed: FDA_Inspections

> FDA Inspection 1179443 for REDHILL BIOPHARMA INC. on August 25, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1179443
- Company Name: REDHILL BIOPHARMA INC.
- Inspection Date: 2022-08-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/redhill-biopharma-inc/98fd3f0e-dbc2-4bbf-bfb9-9efd85c352b5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c